Defective lymphoproliferative responses and interleukin-2 production in chronic renal failure patients

被引:0
|
作者
Krishnamurthy, G
Kher, V
Naik, S
机构
[1] SANJAY GANDHI POSTGRAD INST MED SCI,DEPT IMMUNOL,LUCKNOW 226014,UTTAR PRADESH,INDIA
[2] SANJAY GANDHI POSTGRAD INST MED SCI,DEPT NEPHROL,LUCKNOW 226014,UTTAR PRADESH,INDIA
关键词
anti-CD3; cytokines; early renal failure; end stage renal disease; haemodialysis; phytohaemagglutinin; uraemia;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular immune responses were evaluated in 12 early renal failure (ERP) patients who were not on maintenance haemodialysis, 43 end stage renal disease (ESRD) patients on haemodialysis (no) and 25 healthy volunteers. Peripheral blood mononuclear cells (PBMC) of ERF and ESRD patients on no had a significantly diminished lymphoproliferative responses to phytohaemagglutinin and a monoclonal antibody to the CD3 (anti-CD3) receptor on T-cells as compared to normals. The interleukin-2 (IL-2) production by the PBMC was also significantly reduced in renal failure patients as compared to normals. These data suggest that both IL-2 dependent and IL-2 independent T-cell functions are defective in renal failure patients.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [41] Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure
    Buraczynska, Monika
    Ksiazek, Piotr
    Kubit, Piotr
    Zaluska, Wojciech
    CYTOKINE, 2006, 36 (3-4) : 167 - 172
  • [42] Fluoride aggravation of oxidative stress in patients with chronic renal failure
    Bober, Joanna
    Kwiatkowska, Ewa
    Kedzierska, Karolina
    Olszewska, Maria
    Stachowska, Ewa
    Ciechanowski, Kazimierz
    Chlubek, Dariusz
    FLUORIDE, 2006, 39 (04) : 302 - 309
  • [43] Cerebral haemodynamics in patients with chronic renal failure: effects of haemodialysis
    Skinner, H
    Mackaness, C
    Bedforth, N
    Mahajan, R
    BRITISH JOURNAL OF ANAESTHESIA, 2005, 94 (02) : 203 - 205
  • [44] Nutritional status in chronic renal failure patients assisted at the hemodialysis program of the "hermanos ameijeiras" hospital
    Perez, V. Ordonez
    Hernandez, E. Barranco
    Bustillo, G. Guerra
    Penie, J. Barreto
    Porben, S. Santana
    Borras, A. Espinosa
    Gonzalez, C. Martinez
    Martinez, Anias
    NUTRICION HOSPITALARIA, 2007, 22 (06) : 677 - 694
  • [45] A Belgian registry of interleukin-2 administration for treatment of metastatic renal cell cancer and confrontation with literature data
    Bambust, I.
    Van Aelst, F.
    Joosens, E.
    Schallier, D.
    Kalantari, H. Rezaei
    Paulus, R.
    Renard, V.
    Clausse, M.
    Duck, L.
    Luce, S.
    Pierre, P.
    Van Belle, S.
    Rottey, S.
    ACTA CLINICA BELGICA, 2007, 62 (04) : 223 - 229
  • [46] The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro
    Rudolf, S
    Peters, M
    Rothermundt, M
    Arolt, V
    Kirchner, H
    NEUROPSYCHOBIOLOGY, 2002, 46 (04) : 180 - 185
  • [47] Antigen-induced interferon-gamma and interleukin-2 responses of cattle inoculated with Mycobacterium bovis
    Ng, KH
    Aldwell, FE
    Wedlock, DN
    Watson, JD
    Buddle, BM
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 57 (1-2) : 59 - 68
  • [48] Lipid hydroperoxides: Elevated levels in patients on haemodialysis and patients with chronic renal failure
    Mondorf, UF
    Schmidt, R
    Siegers, J
    Gross, W
    Geiger, H
    Scheuermann, EH
    NEPHROLOGY, 2000, 5 (1-2) : 65 - 70
  • [49] Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma:: results of a phase II trial
    Schmidinger, M
    Steger, GG
    Wenzel, C
    Locker, GJ
    Brodowicz, T
    Budinsky, AC
    Wiltschke, C
    Kramer, G
    Marberger, M
    Zielinski, CC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (07) : 395 - 400
  • [50] Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial
    Manuela Schmidinger
    Günther G. Steger
    Catharina Wenzel
    Gottfried J. Locker
    Thomas Brodowicz
    Alexandra C. Budinsky
    Christoph Wiltschke
    Gero Kramer
    Michael Marberger
    Christoph C. Zielinski
    Cancer Immunology, Immunotherapy, 2000, 49 : 395 - 400